H8 Sharing Data and Assets Across Industry and Academia to Drive the Science Base and Innovation
|Track:||Industry - Academic Relations|
|Target Audience:||All Audiences|
|Moderator:||Malcolm Skingle, Ph.D., GlaxoSmithKline|
|Speakers:||Rowan Douglas, Willis Research Network|
|Helene Rutledge , GlaxoSmithKline|
|Bin Yan, Ph.D., LL.B. , University of Miami W.H Coulter Center|
Increasingly, technology-driven companies are looking to de-risk research and development projects by sharing data and proprietary assets with selected academics in order to expand parts of the science base and to increase their internal knowledge. Many of these projects are co-funded by funding agencies on the assumption that the data generated is deposited into the public domain for all to access. This has driven an interesting dynamic where the corporate company has wanted increased levels of openness and some universities wish to adopt a more secretive approach. Several companies driven by global technology have developed innovative business models with certain universities in recent years in order to increase R&D productivity. These models will be described in detail in order to share what many in industries now consider to be best practice. Recent novel examples from different industrial sectors will be described, including business models from GlaxoSmithKline, Proctor and Gamble, and Willis Ltd, a company specializing in risk adjustment.